MDM2 and breast cancer: Using TCGA RNA-seq data, we identified differentially edited 3’UTRs in breast cancers and experimentally validated editing sites in the 3’UTRs of MDM2, GINS1, and F11R regulated by ADAR1 with protein level implications.